IL1B and COVID-19: Direct comparisons between patients with influenza and COVID-19 (including patients from both groups with acute respiratory failure) demonstrate that those with influenza had increased IFN pathway responses and reduced TNF and IL-1β responses compared to patients with COVID-19 [6, 7].